Literature DB >> 23045622

Excess mortality associated with influenza A and B virus in Hong Kong, 1998-2009.

Peng Wu1, Edward Goldstein, Lai Ming Ho, Lin Yang, Hiroshi Nishiura, Joseph T Wu, Dennis K M Ip, Shuk-Kwan Chuang, Thomas Tsang, Benjamin J Cowling.   

Abstract

BACKGROUND: Although deaths associated with laboratory-confirmed influenza virus infections are rare, the excess mortality burden of influenza estimated from statistical models may more reliably quantify the impact of influenza in a population.
METHODS: We applied age-specific multiple linear regression models to all-cause and cause-specific mortality rates in Hong Kong from 1998 through 2009. The differences between estimated mortality rates in the presence or absence of recorded influenza activity were used to estimate influenza-associated excess mortality.
RESULTS: The annual influenza-associated all-cause excess mortality rate was 11.1 (95% confidence interval [CI], 7.2-14.6) per 100,000 person-years. We estimated an average of 751 (95% CI, 488-990) excess deaths associated with influenza annually from 1998 through 2009, with 95% of the excess deaths occurring in persons aged ≥65 years. Most of the influenza-associated excess deaths were from respiratory (53%) and cardiovascular (18%) causes. Influenza A(H3N2) epidemics were associated with more excess deaths than influenza A(H1N1) or B during the study period.
CONCLUSIONS: Influenza was associated with a substantial number of excess deaths each year, mainly among the elderly, in Hong Kong in the past decade. The influenza-associated excess mortality rates were generally similar in Hong Kong and the United States.

Entities:  

Mesh:

Year:  2012        PMID: 23045622      PMCID: PMC3502382          DOI: 10.1093/infdis/jis628

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  47 in total

1.  Estimating deaths due to influenza and respiratory syncytial virus.

Authors:  Nigel J Gay; Nick J Andrews; Caroline L Trotter; W John Edmunds
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

2.  Unveiling the burden of influenza-associated pneumococcal pneumonia.

Authors:  Carlos G Grijalva; Marie R Griffin
Journal:  J Infect Dis       Date:  2011-12-07       Impact factor: 5.226

3.  Elevated influenza-related excess mortality in South African elderly individuals, 1998-2005.

Authors:  Cheryl Cohen; Lone Simonsen; Jong-Won Kang; Mark Miller; Jo McAnerney; Lucille Blumberg; Barry Schoub; Shabir A Madhi; Cécile Viboud
Journal:  Clin Infect Dis       Date:  2010-11-11       Impact factor: 9.079

4.  Estimating influenza-associated deaths in the United States.

Authors:  William W Thompson; Matthew R Moore; Eric Weintraub; Po-Yung Cheng; Xiaoping Jin; Carolyn B Bridges; Joseph S Bresee; David K Shay
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

5.  Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data.

Authors:  Jonathan Dushoff; Joshua B Plotkin; Cecile Viboud; David J D Earn; Lone Simonsen
Journal:  Am J Epidemiol       Date:  2005-11-30       Impact factor: 4.897

6.  Influenza in children. Relationship to other respiratory agents.

Authors:  W P Glezen; A Paredes; L H Taber
Journal:  JAMA       Date:  1980-04-04       Impact factor: 56.272

7.  Influenza-associated hospitalizations in the United States.

Authors:  William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Carolyn B Bridges; Nancy J Cox; Keiji Fukuda
Journal:  JAMA       Date:  2004-09-15       Impact factor: 56.272

8.  Recent human influenza A/H3N2 virus evolution driven by novel selection factors in addition to antigenic drift.

Authors:  Matthew J Memoli; Brett W Jagger; Vivien G Dugan; Li Qi; Jadon P Jackson; Jeffery K Taubenberger
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

9.  Comparing pandemic to seasonal influenza mortality: moderate impact overall but high mortality in young children.

Authors:  Cees C van den Wijngaard; Liselotte van Asten; Marion P G Koopmans; Wilfrid van Pelt; Nico J D Nagelkerke; Cornelia C H Wielders; Alies van Lier; Wim van der Hoek; Adam Meijer; Gé A Donker; Frederika Dijkstra; Carel Harmsen; Marianne A B van der Sande; Mirjam Kretzschmar
Journal:  PLoS One       Date:  2012-02-03       Impact factor: 3.240

10.  The impact of pandemic influenza A (H1N1) 2009 on the circulation of respiratory viruses 2009-2011.

Authors:  Gannon C Mak; Ann H Wong; Winnie Y Y Ho; Wilina Lim
Journal:  Influenza Other Respir Viruses       Date:  2012-01-02       Impact factor: 4.380

View more
  72 in total

1.  Years of life lost in the first wave of the 2009 influenza A(H1N1) pandemic in Hong Kong.

Authors:  Ying Zhou; Eric H Y Lau; Dennis K M Ip; Hiroshi Nishiura; Gabriel M Leung; Wing-Hong Seto; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2013-08-26       Impact factor: 4.897

2.  Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).

Authors:  Luzhao Feng; Peng Yang; Tao Zhang; Juan Yang; Chuanxi Fu; Ying Qin; Yi Zhang; Chunna Ma; Zhaoqiu Liu; Quanyi Wang; Genming Zhao; Hongjie Yu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 3.  Hospitalization Fatality Risk of Influenza A(H1N1)pdm09: A Systematic Review and Meta-Analysis.

Authors:  Jessica Y Wong; Heath Kelly; Chung-Mei M Cheung; Eunice Y Shiu; Peng Wu; Michael Y Ni; Dennis K M Ip; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2015-07-18       Impact factor: 4.897

4.  Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study.

Authors:  Shuo Feng; Susan S Chiu; Eunice L Y Chan; Mike Y W Kwan; Joshua S C Wong; Chi-Wai Leung; Yiu Chung Lau; Sheena G Sullivan; J S Malik Peiris; Benjamin J Cowling
Journal:  Lancet Respir Med       Date:  2018-11-12       Impact factor: 30.700

5.  Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach.

Authors:  Weina Sun; Ericka Kirkpatrick; Megan Ermler; Raffael Nachbagauer; Felix Broecker; Florian Krammer; Peter Palese
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

6.  Effectiveness of Partial and Full Influenza Vaccination Among Children Aged <9 Years in Hong Kong, 2011-2019.

Authors:  Huiying Chua; Susan S Chiu; Eunice L Y Chan; Shuo Feng; Mike Y W Kwan; Joshua S C Wong; J S Malik Peiris; Benjamin J Cowling
Journal:  J Infect Dis       Date:  2019-10-08       Impact factor: 5.226

7.  Heterogeneity in Estimates of the Impact of Influenza on Population Mortality: A Systematic Review.

Authors:  Li Li; Jessica Y Wong; Peng Wu; Helen S Bond; Eric H Y Lau; Sheena G Sullivan; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2018-02-01       Impact factor: 4.897

8.  Influenza-Associated Excess Mortality in South Korea.

Authors:  Minah Park; Peng Wu; Edward Goldstein; Woo Joo Kim; Benjamin J Cowling
Journal:  Am J Prev Med       Date:  2015-11-29       Impact factor: 5.043

9.  Regression approaches in the test-negative study design for assessment of influenza vaccine effectiveness.

Authors:  H S Bond; S G Sullivan; B J Cowling
Journal:  Epidemiol Infect       Date:  2016-01-06       Impact factor: 2.451

10.  Age- and sex-related risk factors for influenza-associated mortality in the United States between 1997-2007.

Authors:  Talia M Quandelacy; Cecile Viboud; Vivek Charu; Marc Lipsitch; Edward Goldstein
Journal:  Am J Epidemiol       Date:  2013-11-04       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.